These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8151310)

  • 41. Synthesis, characterization, and antitumor activity of 1,2-bis(diphenylphosphino) ethane platinum(II) and palladium(II) complexes.
    Khokhar AR; Xu QY; Siddik ZH
    J Inorg Biochem; 1990 Jun; 39(2):117-23. PubMed ID: 2380705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, structure, and antitumor activity of 1,3-dithiol- and 1,3-dithiolan-2-ylidenemalonatoplatinum(II) complexes.
    Sohn YS; Kim KM; Jeong JH; Noh DY; Lee CO; Choi SU
    J Inorg Biochem; 1994 May; 54(2):107-14. PubMed ID: 8176395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II).
    Wilkoff LJ; Dulmadge EA; Trader MW; Harrison SD; Griswold DP
    Cancer Chemother Pharmacol; 1987; 20(2):96-100. PubMed ID: 3664938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparation, characterization, and antitumor activity of water-soluble aminoalkanol platinum(II) complexes.
    Khokhar AR; Xu QY; Newman RA; Siddik ZH
    J Inorg Biochem; 1991 Jul; 43(1):57-63. PubMed ID: 1940901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antitumor activity of l-OHP in mice.
    Mathé G; Kidani Y; Noji M; Maral R; Bourut C; Chenu E
    Cancer Lett; 1985 Jun; 27(2):135-43. PubMed ID: 4039973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and antitumor activity of (diamine)platinum(II) complexes of benzylmalonate derivatives.
    Lee YA; Chung YK; Sohn YS
    J Inorg Biochem; 1997 Dec; 68(4):289-94. PubMed ID: 9397577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coordination modes vs. antitumor activity: synthesis and antitumor activity of novel platinum(II) complexes of N-substituted amino dicarboxylic acids.
    Kim YS; Song R; Chung HC; Jun MJ; Sohn YS
    J Inorg Biochem; 2004 Jan; 98(1):98-104. PubMed ID: 14659638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential antitumor activity and toxicity of isomeric 1,2-diaminocyclohexane platinum (II) complexes.
    Siddik ZH; al-Baker S; Burditt TL; Khokhar AR
    J Cancer Res Clin Oncol; 1993; 120(1-2):12-6. PubMed ID: 8270602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the effectivity of two diaminocyclohexane Pt-complexes.
    Balázová E; Hrubisko M; Ujházy V
    Neoplasma; 1985; 32(5):537-42. PubMed ID: 4069288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antitumor activity of platinum(II) complexes of 1,2-diamino-cyclohexane isomers.
    Kidani Y; Noji M; Tashiro T
    Gan; 1980 Oct; 71(5):637-43. PubMed ID: 7227714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis, characterization and preliminary cytotoxicity assays of poly(ethylene glycol)-malonato-Pt-DACH conjugates.
    Furin A; Guiotto A; Baccichetti F; Pasut G; Deuschel C; Bertani R; Veronese FM
    Eur J Med Chem; 2003; 38(7-8):739-49. PubMed ID: 12932905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new orally active antitumor 1R,2R-cyclohexanediamine-platinum(IV) complex: trans-(n-valerato)chloro(1R,2R-cyclohexanediamine) (oxalato)platinum(IV).
    Kizu R; Nakanishi T; Hayakawa K; Matsuzawa A; Eriguchi M; Takeda Y; Akiyama N; Tashiro T; Kidani Y
    Cancer Chemother Pharmacol; 1999; 43(2):97-105. PubMed ID: 9923814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug resistance induction and cross-resistance studies with Pt-complexes.
    Hrubisko M; Balázová E; Ujházy V
    Neoplasma; 1984; 31(6):649-53. PubMed ID: 6542968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of DNA repair in resistance of L1210 cells to isomeric 1,2-diaminocyclohexaneplatinum complexes and ultraviolet irradiation.
    Jennerwein MM; Eastman A; Khokhar AR
    Mutat Res; 1991 Jan; 254(1):89-96. PubMed ID: 1986276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and antitumor activity of ammine/amine platinum(II) and (IV) complexes.
    Khokhar AR; Deng Y; al-Baker S; Yoshida M; Siddik ZH
    J Inorg Biochem; 1993 Aug; 51(3):677-87. PubMed ID: 8409984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytotoxicity and antitumor activity of platinum (II) complexes of aromatic and cycloalkanecarboxylic acid hydrazides.
    Kushev DN; Spassovska NC; Taxirov SI; Grancharov KC
    Z Naturforsch C J Biosci; 1997; 52(1-2):49-54. PubMed ID: 9162170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Water-soluble N-substituted iminodiacetato(1,2-diaminocyclohexane)-platinum(II) complexes as potential antitumor agents.
    Hacker MP; Khokhar AR; Krakoff IH; Brown DB; McCormack JJ
    Cancer Res; 1986 Dec; 46(12 Pt 1):6250-4. PubMed ID: 3779645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Asymmetrically substituted ethylenediamine platinum(II) complexes as antitumor agents: synthesis and structure-activity relationships.
    Mailliet P; Segal-Bendirdjian E; Kozelka J; Barreau M; Baudoin B; Bissery MC; Gontier S; Laoui A; Lavelle F; Le Pecq JB
    Anticancer Drug Des; 1995 Jan; 10(1):51-73. PubMed ID: 7695813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced antitumor activity [correction for activitiy] of trans(+/-)-1,2-diaminocyclo- hexaneglutamatoplatinum(II) formulated with stealth liposome.
    Han I; Kim OJ; Lee GY; Sung YK; Song R; Sohn YS
    Bioorg Med Chem; 2003 Dec; 11(24):5443-7. PubMed ID: 14642589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platinum and palladium complexes of 3-methyl orotic acid: a route toward palladium complexes with good antitumor activity.
    Castan P; Colacio-Rodriguez E; Beauchamp AL; Cros S; Wimmer S
    J Inorg Biochem; 1990 Mar; 38(3):225-39. PubMed ID: 2329345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.